Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: Relationship between relaxivities, electrostatic forces, and chemical composition

The purpose of this study was to investigate the changes in electrostatic and magnetic resonance (MR) properties observed when MR contrast agents (CAs) (Feridex®, MION‐46L, or G5‐dendrimer‐DOTA‐Gd) are combined with transfection agents (TAs) under various conditions for use as a CA‐TA complex basis for cellular labeling and MRI. CAs were incubated with various classes of TAs for 0–48 hr in solutions of varying concentrations and pH values. NMR relaxation rates (1/T1, 1/T2), MRI and zeta potential (ZP) of CA‐TA solutions were measured. TAs decreased the 1/T1 and 1/T2 of G5‐DOTA‐Gd, Feridex®, and MION‐46L by 0–95%. Altering the pH of G5‐DOTA‐Gd‐TA decreased the T1‐weighted signal intensity (SI) on MRI from 0 to 78%. Measured ZP values for G5‐DOTA‐Gd, Feridex®, and MION‐46L were −51, −41, and −2.0 mV, respectively. The TA LV had a negative ZP, while the other TAs had ZPs ranging from +20 to +65 mV. The alteration of the ZP and NMR relaxivities of the MR CAs, Feridex®, MION‐46L, and G5‐DOTA‐Gd by TAs has been demonstrated. These results enhance our understanding of the relationship between electrostatic and MR properties. Magn Reson Med 50:275–282, 2003. Published 2003 Wiley‐Liss, Inc.

[1]  R E Jacobs,et al.  Fluorescently detectable magnetic resonance imaging agents. , 1998, Bioconjugate chemistry.

[2]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[3]  A. Maruyama,et al.  A pH-Sensitive Contrast Agent for Functional Magnetic Resonance Imaging (MRI) , 1998 .

[4]  S. Fraser,et al.  A Calcium-Sensitive Magnetic Resonance Imaging Contrast Agent , 1999 .

[5]  P C Lauterbur,et al.  Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.

[6]  P. Schmalbrock,et al.  T1 measurements in cell cultures: A new tool for characterizing contrast agents at 1.5T , 2001, Journal of magnetic resonance imaging : JMRI.

[7]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[8]  A. Maruyama,et al.  Gd3+‐loaded polyion complex for pH depiction with magnetic resonance imaging , 2000 .

[9]  C. Semsarian.  Stem cells in cardiovascular disease: from cell biology to clinical therapy , 2002, Internal medicine journal.

[10]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[11]  Ming Zhao,et al.  Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.

[12]  J. Baker,et al.  DNA complexing with polyamidoamine dendrimers: implications for transfection. , 1999, Bioconjugate chemistry.

[13]  J. Hecker,et al.  Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  S. Fraser,et al.  Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. , 1995, Chemistry & biology.

[15]  Brian D. Athey,et al.  Structural Molecular Dynamics Studies on Polyamidoamine Dendrimers for a Therapeutic Application: Effects of pH and Generation , 2002 .

[16]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[17]  Kevin M. Johnson,et al.  Gadolinium‐bearing red cells as blood pool MRI contrast agents , 1998, Magnetic resonance in medicine.

[18]  J. Bulte,et al.  Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. , 2002, Academic radiology.

[19]  Scott E. Fraser,et al.  A SMART MAGNETIC RESONANCE IMAGING AGENT THAT REPORTS ON SPECIFIC ENZYMATIC ACTIVITY , 1997 .

[20]  R Weissleder,et al.  Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. , 2000, Bioconjugate chemistry.

[21]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[22]  J. Mcdonald,et al.  Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord , 1999, Nature Medicine.

[23]  J A Frank,et al.  Synthesis and relaxometry of high‐generation (G = 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates , 1999, Journal of magnetic resonance imaging : JMRI.

[24]  B. Petersen,et al.  In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Rovaris,et al.  Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. , 1999, Magnetic resonance imaging.

[26]  S Aime,et al.  pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation. , 2001, Journal of the American Chemical Society.

[27]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[28]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[29]  Takuro Niidome,et al.  In vitro gene transfection using dendritic poly(L-lysine). , 2002, Bioconjugate chemistry.

[30]  R. Weissleder,et al.  Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro , 1995, Investigative radiology.

[31]  A. Maruyama,et al.  Gd(3+)-loaded polyion complex for pH depiction with magnetic resonance imaging. , 2000, Journal of biomedical materials research.

[32]  D. Luo,et al.  Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery , 2002 .

[33]  R. Haag,et al.  Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.

[34]  Y. Ogino,et al.  Catalytic activity of the liquid Na-Pb alloy system. , 1978 .

[35]  Robert J Gillies,et al.  In vivo magnetic resonance imaging of tissue pH using a novel pH-sensitive contrast agent, GdDOTA-4AmP. , 2002, Academic radiology.